Expansion of variant panels in newborn screening algorithms to identify cystic fibrosis: A retrospective analysis of 25 years of genotypes and implications on diagnosis

Jaime E. Hale(University of Massachusetts Chan Medical School), Anne Marie Comeau(University of Massachusetts Chan Medical School), Lael M. Yonker(The University of Texas Southwestern Medical Center), G. Sawicki(Boston Children's Hospital), Henry L. Dorkin(Boston Children's Hospital), Nico W. Vehse(Baystate Medical Center), Jacalyn Gerstel-Thompson(University of Massachusetts Chan Medical School), Anne M. Counihan(University of Massachusetts Chan Medical School), Ted Kremer(University of Massachusetts Chan Medical School), Richard B. Parad(Brigham and Women's Hospital), Binod Kumar(University of Massachusetts Chan Medical School)
Genetics in Medicine
October 30, 2025
10.1016/j.gim.2025.101629
Cited by 0

Related Papers

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation
|Thorax|2011|501
Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis
|New England Journal of Medicine|1993|458
Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs
|Human Molecular Genetics|1993|414
Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project
|The American Journal of Human Genetics|2019|307
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
|Nature Immunology|2023|281